Jessica Marcandalli

Title: **Jessica Marcandalli: Innovator in Protein Nanostructures**

Introduction

Jessica Marcandalli, an accomplished inventor based in Bellinzona, Switzerland, has made significant strides in the field of biotechnology. With a focus on self-assembling protein nanostructures, she holds three patents that demonstrate her innovative approach to tackling complex scientific challenges. Her work has important implications for the development of vaccines and therapeutics.

Latest Patents

Jessica's most recent patents include the groundbreaking invention of self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins. The patents disclose nanostructures comprising a plurality of first assemblies made up of identical first polypeptides, alongside second assemblies with different polypeptides. These assemblies non-covalently interact to form nanostructures that are capable of displaying multiple copies of paramyxovirus and/or pneumovirus F proteins or their antigenic fragments on the exterior. This innovative design holds potential for advancements in immunology and targeted drug delivery.

Career Highlights

Jessica Marcandalli has contributed her expertise to renowned institutions such as the University of Washington and the Institute for Research in Biomedicine. Her roles at these organizations allowed her to push the boundaries of research in biomedicine, furthering the understanding of protein interactions and their applications in health and disease.

Collaborations

Throughout her career, Jessica has collaborated with esteemed colleagues, including Neil P. King and David Baker. These partnerships have fostered a collaborative research environment that has been integral to her success, enabling the sharing of knowledge and resources critical to her innovative projects.

Conclusion

Jessica Marcandalli stands out as a leading figure in the innovation of protein nanostructures. Her ongoing commitment to research and her impressive portfolio of patents highlight her role as a key contributor to advancements in biotechnology. As she continues her work, the scientific community eagerly anticipates the potential impact of her inventions on future medical therapies.